Early-Phase Clinical Trials at Our Dedicated Facility

VILO Research group - Phase I unit

At Vilo Research Group, Inc., we are proud to offer a state-of-the-art Phase 1 clinical trial unit dedicated to advancing medical research and innovation. Our facility is equipped with the latest technology and staffed by a highly skilled team of professionals committed to ensuring the highest standards of safety, compliance, and patient care.

We specialize in early-phase clinical trials, providing essential data to assess the safety, dosage, and pharmacokinetics of new drugs or treatments. With our expertise and world-class infrastructure, we support the development of groundbreaking therapies, helping to bring promising new treatments to market efficiently and responsibly.

Phase I capabilities

Located in Katy, TX, our 2,500 sq. ft. Kingsland Phase I Facility is purpose-built for outpatient and short-stay clinical research. 

The facility supports:

  • First-in-Human (FIH) studies
  • SAD/MAD studies
  • Bioavailability and bioequivalence
  • PK/PD studies and vaccine immunogenicity
  • Drug-drug interaction and food effect studies

Facility Highlights:

  • 5 patient rooms with full monitoring capabilities
  • CLIA-waived laboratory for real-time sample processing
  • Temperature-controlled pharmacy and crash-cart-ready emergency zone
  • EDC, eSource, and secure trial data systems.

Address:

3100 Broadway St #104E, Houston, TX 77017

Contacts:

Email: feasibility@viloresearchgroup.com
Phone: +1 (832) 821-1515
Fax: +1 (409) 684 3639